Company will sell shares to Essex Woodlands at 4% discount
By Susanna Moon
Chicago, Aug. 26 – AxoGen, Inc. is offering to sell $17.5 million of its common stock to Essex Woodlands Fund IX, LP, according to a 424B5 filing with the Securities and Exchange Commission.
The company will sell 4,861,111 shares at $3.60 each, which is a 4% discount to the company’s closing price on Aug. 25.
Proceeds will be used for sales and marketing and general working capital purposes.
AxoGen is a regenerative medicine company based in Alachua, Fla.
| Issuer: | AxoGen, Inc.
|
| Issue: | Common stock
|
| Amount: | $17,499,999.60
|
| Shares: | 4,861,111
|
| Price: | $3.60
|
| Warrants: | No
|
| Pricing date: | Aug. 26
|
| Stock symbol: | Nasdaq: AXGN
|
| Stock price: | $3.75 at close Aug. 25
|
| Market capitalization: | $93.5 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
